Average Co-Inventor Count = 3.59
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Actelion Pharmaceuticals Ltd (8 from 217 patents)
2. Idorsia Pharmaceuticals Ltd (4 from 77 patents)
3. Santhera Pharmaceuticals Ag (0 patent)
12 patents:
1. 11834443 - Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
2. 11390615 - Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenox
3. 10836754 - Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
4. 10385043 - Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
5. 9617250 - Pyridin-4-yl derivatives
6. 9133179 - 2-methoxy-pyridin-4-yl-derivatives
7. 8658675 - Pyridin-4-yl derivatives
8. 8598208 - Pyridine derivatives as S1P1/EDG1 receptor modulators
9. 8575200 - Pyridin-2-yl derivatives as immunomodulating agents
10. 8410151 - Aminomethyl benzene derivatives
11. 8299086 - Pyrimidine derivatives
12. 8148410 - Thiophene derivatives as agonists of S1P1/EDG1